Reporter: Aviva Lev-Ari, PhD, RN
DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD
April 22, 2013 by 2012pharmaceutical
3 Responses
Leave a Reply
-
Recent Posts
- Tweets and Retweets by @AVIVA1950 and by @pharma_BI for 15th Annual Personalized Medicine Conference at Harvard Medical School – THE PARADIGM EVOLVES, November 13 – 14, 2019 • Harvard Medical School, Boston, MA November 15, 2019
- CRISPR companies calling for article retraction from Nature Methods – If the same or similar sequence of letters appears elsewhere in the genome, that can result in an unintentional or off-target edit – Concerns of Harm caused by Gene Editing using CRISPR-Cas9 November 12, 2019
- Contributions to Neuronal Systems by University Professors Eve Marder and Irv Epstein at Brandeis University November 12, 2019
- New Mutant KRAS Inhibitors Are Showing Promise in Cancer Clinical Trials: Hope For the Once ‘Undruggable’ Target November 11, 2019
- Measles causes amnesia of the immune system November 9, 2019
- DISCOVER BRIGHAM | NOVEMBER 7, 2019, 10AM – 6PM November 6, 2019
- Advancing Drug Development – 12/12/2019, 8:30AM – 8:30PM at The University of Massachusetts Club, One Beacon Street, Boston, MA November 4, 2019
- Transthyretin amyloid cardiomyopathy (ATTR-CM): U.S. FDA APPROVES VYNDAQEL® AND VYNDAMAX™ for this Rare and Fatal Disease October 29, 2019
- Cardiac MRI Imaging Breakthrough: The First AI-assisted Cardiac MRI Scan Solution, HeartVista Receives FDA 510(k) Clearance for One Click™ Cardiac MRI Package October 29, 2019
- Deep Learning extracts Histopathological Patterns and accurately discriminates 28 Cancer and 14 Normal Tissue Types: Pan-cancer Computational Histopathology Analysis October 28, 2019
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
amnondanzig1724
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
This again raises questions in my mind about methyl donor deficiency (methionine) and cancer resistance. Prof. Yves Ingenbleek did not investigate it, but he was not unaware of this. This is perhaps the other side of the coin with veganism.
[…] DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James… […]
[…] https://pharmaceuticalintelligence.com/2013/04/22/dna-methultransferases-implications-to-epigenetic-r… […]